In recent days, Edwards Lifesciences announced positive long-term clinical trial results for its SAPIEN TAVR technology and successful patient outcomes from real-world data on the SAPIEN M3 and EVOQUE ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback